226 related articles for article (PubMed ID: 27135737)
1. Cancer Targeted Enzymatic Theranostic Prodrug: Precise Diagnosis and Chemotherapy.
Shin WS; Han J; Verwilst P; Kumar R; Kim JH; Kim JS
Bioconjug Chem; 2016 May; 27(5):1419-26. PubMed ID: 27135737
[TBL] [Abstract][Full Text] [Related]
2. A DT-diaphorase responsive theranostic prodrug for diagnosis, drug release monitoring and therapy.
Liu P; Xu J; Yan D; Zhang P; Zeng F; Li B; Wu S
Chem Commun (Camb); 2015 Jun; 51(46):9567-70. PubMed ID: 25971544
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial induced and self-monitored intrinsic apoptosis by antitumor theranostic prodrug: in vivo imaging and precise cancer treatment.
Kumar R; Han J; Lim HJ; Ren WX; Lim JY; Kim JH; Kim JS
J Am Chem Soc; 2014 Dec; 136(51):17836-43. PubMed ID: 25402959
[TBL] [Abstract][Full Text] [Related]
4. A Smart Theranostic Prodrug System Activated by Reactive Oxygen Species for Regional Chemotherapy of Metastatic Cancer.
Liu L; Liu F; Liu D; Yuan W; Zhang M; Wei P; Yi T
Angew Chem Int Ed Engl; 2022 Mar; 61(12):e202116807. PubMed ID: 35068033
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and biological evaluation of NAD(P)H: Quinone oxidoreductase (NQO1)-targeted oridonin prodrugs possessing indolequinone moiety for hypoxia-selective activation.
Xu S; Yao H; Pei L; Hu M; Li D; Qiu Y; Wang G; Wu L; Yao H; Zhu Z; Xu J
Eur J Med Chem; 2017 May; 132():310-321. PubMed ID: 28395199
[TBL] [Abstract][Full Text] [Related]
6. An activatable prodrug for the treatment of metastatic tumors.
Kim EJ; Bhuniya S; Lee H; Kim HM; Cheong C; Maiti S; Hong KS; Kim JS
J Am Chem Soc; 2014 Oct; 136(39):13888-94. PubMed ID: 25238144
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of NQO1-activated prodrugs of podophyllotoxin as antitumor agents.
Qu Y; Zhang C; Ma X; Gao Y; Liu J; Wu L
Bioorg Med Chem; 2020 Dec; 28(24):115821. PubMed ID: 33091789
[TBL] [Abstract][Full Text] [Related]
8. Esterase-activatable β-lapachone prodrug micelles for NQO1-targeted lung cancer therapy.
Ma X; Huang X; Moore Z; Huang G; Kilgore JA; Wang Y; Hammer S; Williams NS; Boothman DA; Gao J
J Control Release; 2015 Feb; 200():201-11. PubMed ID: 25542645
[TBL] [Abstract][Full Text] [Related]
9. Polyamine-Targeting Gefitinib Prodrug and its Near-Infrared Fluorescent Theranostic Derivative for Monitoring Drug Delivery and Lung Cancer Therapy.
Song X; Han X; Yu F; Zhang X; Chen L; Lv C
Theranostics; 2018; 8(8):2217-2228. PubMed ID: 29721074
[TBL] [Abstract][Full Text] [Related]
10. NQO1-selective activated prodrugs of combretastatin A-4: Synthesis and biological evaluation.
Zhang C; Qu Y; Ma X; Li M; Li S; Li Y; Wu L
Bioorg Chem; 2020 Oct; 103():104200. PubMed ID: 32890998
[TBL] [Abstract][Full Text] [Related]
11. 10-Boronic acid substituted camptothecin as prodrug of SN-38.
Wang L; Xie S; Ma L; Chen Y; Lu W
Eur J Med Chem; 2016 Jun; 116():84-89. PubMed ID: 27060760
[TBL] [Abstract][Full Text] [Related]
12. A highly GSH-sensitive SN-38 prodrug with an "OFF-to-ON" fluorescence switch as a bifunctional anticancer agent.
Whang CH; Yoo E; Hur SK; Kim KS; Kim D; Jo S
Chem Commun (Camb); 2018 Aug; 54(65):9031-9034. PubMed ID: 30047958
[TBL] [Abstract][Full Text] [Related]
13. Programmed activation of cancer cell apoptosis: A tumor-targeted phototherapeutic topoisomerase I inhibitor.
Shin WS; Han J; Kumar R; Lee GG; Sessler JL; Kim JH; Kim JS
Sci Rep; 2016 Jul; 6():29018. PubMed ID: 27374023
[TBL] [Abstract][Full Text] [Related]
14. Bifunctional supramolecular prodrug vesicles constructed from a camptothecin derivative with a water-soluble pillar[5]arene for cancer diagnosis and therapy.
Sun G; He Z; Hao M; Xu Z; Hu XY; Zhu JJ; Wang L
Chem Commun (Camb); 2019 Sep; 55(73):10892-10895. PubMed ID: 31436766
[TBL] [Abstract][Full Text] [Related]
15. The synthesis of a c(RGDyK) targeted SN38 prodrug with an indolequinone structure for bioreductive drug release.
Huang B; Desai A; Tang S; Thomas TP; Baker JR
Org Lett; 2010 Apr; 12(7):1384-7. PubMed ID: 20192275
[TBL] [Abstract][Full Text] [Related]
16. Intracellular Enzyme-Responsive Profluorophore and Prodrug Nanoparticles for Tumor-Specific Imaging and Precise Chemotherapy.
Pei Q; Lu S; Zhou J; Jiang B; Li C; Xie Z; Jing X
ACS Appl Mater Interfaces; 2021 Dec; 13(50):59708-59719. PubMed ID: 34879654
[TBL] [Abstract][Full Text] [Related]
17. An activatable theranostic for targeted cancer therapy and imaging.
Bhuniya S; Maiti S; Kim EJ; Lee H; Sessler JL; Hong KS; Kim JS
Angew Chem Int Ed Engl; 2014 Apr; 53(17):4469-74. PubMed ID: 24644015
[TBL] [Abstract][Full Text] [Related]
18. Self-Strengthened Oxidation-Responsive Bioactivating Prodrug Nanosystem with Sequential and Synergistically Facilitated Drug Release for Treatment of Breast Cancer.
Wang K; Yang B; Ye H; Zhang X; Song H; Wang X; Li N; Wei L; Wang Y; Zhang H; Kan Q; He Z; Wang D; Sun J
ACS Appl Mater Interfaces; 2019 May; 11(21):18914-18922. PubMed ID: 31055911
[TBL] [Abstract][Full Text] [Related]
19. Benzyl ether-linked glucuronide derivative of 10-hydroxycamptothecin designed for selective camptothecin-based anticancer therapy.
Leu YL; Chen CS; Wu YJ; Chern JW
J Med Chem; 2008 Mar; 51(6):1740-6. PubMed ID: 18318465
[TBL] [Abstract][Full Text] [Related]
20. Rapidly cell-penetrating and reductive milieu-responsive nanoaggregates assembled from an amphiphilic folate-camptothecin prodrug for enhanced drug delivery and controlled release.
Xu Z; Hou M; Shi X; Gao YE; Xue P; Liu S; Kang Y
Biomater Sci; 2017 Feb; 5(3):444-454. PubMed ID: 28058423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
